AOC1 Knockout cell line （NK-92）

The AOC1 Knockout cell line (NK-92) is primarily utilized in cancer immunotherapy research and the study of natural killer (NK) cell biology This product is particularly effective in evaluating the role of the AOC1 gene in cytotoxicity against tumor cells Researchers can implement the AOC1 Knockout NK-92 cell line in various experimental contexts including co-culture assays with cancer cell lines to determine the influence of AOC1 knockout on NK cell activation and tumor cell suppression

In clinical settings the cell line serves as a model for designing enhanced NK cell therapies allowing investigators to streamline workflows through standardized protocols that assess NK cell functionality and specificity The practical benefits of using the AOC1 Knockout cell line include improved understanding of immune evasion mechanisms in tumors and the potential to tailor immunotherapeutic strategies This product excels in techniques such as flow cytometry and cytotoxicity assays providing reliable data for advancing therapeutic applications